tiprankstipranks
Advertisement
Advertisement
AAVantgarde Bio Showcases Retinal Gene Therapy Programs at RTIS Summit
PremiumPrivate CompaniesAAVantgarde Bio Showcases Retinal Gene Therapy Programs at RTIS Summit
4d ago
AAVantgarde Bio – Weekly Recap
Premium
Private Companies
AAVantgarde Bio – Weekly Recap
7d ago
AAVantgarde Bio Highlights Ophthalmic Gene Therapy Trials in Inherited Retinal Diseases
Premium
Private Companies
AAVantgarde Bio Highlights Ophthalmic Gene Therapy Trials in Inherited Retinal Diseases
9d ago
AAVantgarde Bio Highlights Southern Europe’s Growing Biotech Investment Appeal
PremiumPrivate CompaniesAAVantgarde Bio Highlights Southern Europe’s Growing Biotech Investment Appeal
1M ago
AAVantgarde Bio Highlighted as Part of Strengthening Southern Europe Biotech Funding Landscape
Premium
Private Companies
AAVantgarde Bio Highlighted as Part of Strengthening Southern Europe Biotech Funding Landscape
1M ago
Conference Panel Participation Underscores AAVantgarde Bio’s Ophthalmology Focus
Premium
Private Companies
Conference Panel Participation Underscores AAVantgarde Bio’s Ophthalmology Focus
1M ago
AAVantgarde Bio Highlights Role in U.K. Ophthalmology Trial Accelerator Summit
PremiumPrivate CompaniesAAVantgarde Bio Highlights Role in U.K. Ophthalmology Trial Accelerator Summit
2M ago
AAVantgarde Bio Emphasizes Gene Therapy Focus on Inherited Retinal Diseases
Premium
Private Companies
AAVantgarde Bio Emphasizes Gene Therapy Focus on Inherited Retinal Diseases
2M ago
Media Spotlight on AAVantgarde Bio’s Gene Therapy Programs for Inherited Retinal Diseases
Premium
Private Companies
Media Spotlight on AAVantgarde Bio’s Gene Therapy Programs for Inherited Retinal Diseases
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100